Acta Neuropathol
- WALTON RL, Koga S, Beasley AI, White LJ, et al
Role of GBA variants in Lewy body disease neuropathology.
Acta Neuropathol. 2024;147:54.
- XU H, Qiu Q, Hu P, Hoxha K, et al
MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway
in neurons.
Acta Neuropathol. 2024;147:55.
Alzheimers Dement
- MAESTRE G, Hill C, Griffin P, Hall S, et al
Promoting diverse perspectives: Addressing health disparities related to
Alzheimer's and all dementias.
Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13752.
- GARCIA-AGUDO LF, Shi Z, Smith IF, Kramar EA, et al
BIN1(K358R) suppresses glial response to plaques in mouse model of Alzheimer's
disease.
Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13767.
- HOWARD R, Cort E, Rawlinson C, Wiegand M, et al
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's
disease dementia: A randomized controlled trial.
Alzheimers Dement. 2024 Mar 13. doi: 10.1002/alz.13766.
Ann Neurol
- PALPATZIS E, Akinci M, Aguilar-Dominguez P, Garcia-Prat M, et al
Lifetime Stressful Events Associated with Alzheimer's Pathologies,
Neuroinflammation and Brain Structure in a Risk Enriched Cohort.
Ann Neurol. 2024 Mar 11. doi: 10.1002/ana.26881.
Biochemistry (Mosc)
- GUSEVA EA, Pavlova JA, Dontsova OA, Sergiev PV, et al
Synthetic Activators of Autophagy.
Biochemistry (Mosc). 2024;89:27-52.
- EREMIN DV, Kondaurova EM, Rodnyy AY, Molobekova CA, et al
Serotonin Receptors as a Potential Target in the Treatment of Alzheimer's
Disease.
Biochemistry (Mosc). 2023;88:2023-2042.
- BURNYASHEVA AO, Stefanova NA, Kolosova NG, Telegina DV, et al
Changes in the Glutamate/GABA System in the Hippocampus of Rats with Age and
during Alzheimer's Disease Signs Development.
Biochemistry (Mosc). 2023;88:1972-1986.
BMC Geriatr
- GE S, Dong F, Tian C, Yang CH, et al
Serum soluble alpha-klotho klotho and cognitive functioning in older adults aged
60 and 79: an analysis of cross-sectional data of the National Health and
Nutrition Examination Survey 2011 to 2014.
BMC Geriatr. 2024;24:245.
- LEE KW, Hong YJ, Yang EJ, Lee SB, et al
Feasibility and usefulness of cognitive monitoring using a new home-based
cognitive test in mild cognitive impairment: a prospective single arm study.
BMC Geriatr. 2024;24:241.
Brain
- RODRIGUEZ-RODRIGUEZ P, Arroyo-Garcia LE, Tsagkogianni C, Li L, et al
A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's
disease vulnerable neurons.
Brain. 2024 Mar 11:awae051. doi: 10.1093.
Curr Alzheimer Res
- DE A, Mishra TK, Saraf S, Tripathy B, et al
A Review onthe Use of Modern Computational Methods in Alzheimer's
Disease-Detection and Prediction.
Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301514240307071217.
- WEAVER D
Drug Design for Alzheimer's Disease: Biologics vs. Small Molecules.
Curr Alzheimer Res. 2024 Mar 8. doi: 10.2174/0115672050301583240307114452.
- YAO J, Kan B, Dong Z, Tang Z, et al
Research Progress of Mitophagy in Alzheimer's Disease.
Curr Alzheimer Res. 2024 Mar 12. doi: 10.2174/0115672050300063240305074310.
J Alzheimers Dis
- SHEN Z, Yang X, Lan Y, Chen G, et al
The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell
Survival in Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231159.
- CAO J, Tang Y, Chen S, Yu S, et al
The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild
Cognitive Impairment and Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231114.
- TRIEU C, van Harten AC, Leeuwis AE, Exalto LG, et al
Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular
Diseases Along the Heart-Brain Axis.
J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231096.
- ZHANG X, Gomez L, Below JE, Naj AC, et al
An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in
Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231075.
- RAMADAN FA, Arani G, Jafri A, Thompson T, et al
Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine
Protects Against Late-Onset Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 13. doi: 10.3233/JAD-231063.
- ZHAI M, Zhang Y, Yan D, Wang Y, et al
Genetic Insights into the Association and Causality Between Blood Metabolites and
Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230985.
- CESANA BM, Bergh S, Ciccone A, Cognat E, et al
Predictors of Nursing Home Placement in a Cohort of European People with
Alzheimer's Disease and Other Dementia Cases Enrolled in SCU-B or Non SCU-B
Centers: The RECage Study.
J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-230878.
- MANDAL PK
Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 4. doi: 10.3233/JAD-240217.
- TERAO I, Kodama W
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab,
Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive
Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic
Review and Networ
J Alzheimers Dis. 2024 Mar 6. doi: 10.3233/JAD-230911.
- SIAFARIKAS N
Neuropsychiatric and Cognitive Symptoms: Two Sides of the Same Coin?
J Alzheimers Dis. 2024;98:75-78.
- MATSUZONO K, Mashiko T, Koide R, Yoshizumi H, et al
Comparison of Prognosis and Cognitive Function of Holistic Neurological Disease:
Tochigi Neurological Disease Cohort Study.
J Alzheimers Dis. 2024;98:275-285.
- NALLAPU BT, Petersen KK, Lipton RB, Davatzikos C, et al
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with
Mild Cognitive Impairment.
J Alzheimers Dis. 2024;98:231-246.
- PRABHAKARAN D, Grant C, Pedraza O, Caselli R, et al
Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive
Impairment Using Medical History, APOE Genotype, and Neuropsychological
Assessment.
J Alzheimers Dis. 2024;98:83-94.
- ROSS JP, Post SG, Scheinfeld L
Lucidity in the Deeply Forgetful: A Scoping Review.
J Alzheimers Dis. 2024;98:3-11.
- PUTIGNANO S, Forgione L, Fusco M, Giacummo A, et al
Early Detection Screening of Cognitive Decline in Patients Over 60 Years:
ELDERCARE Study.
J Alzheimers Dis. 2024;98:145-150.
- ALJASSABI A, Zieneldien T, Kim J, Regmi D, et al
Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.
J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231163.
- BROOKS WH
Polyamine Dysregulation and Nucleolar Disruption in Alzheimer's Disease.
J Alzheimers Dis. 2024 Mar 12. doi: 10.3233/JAD-231184.
- SOARES MARTINS T, Ferreira M, Magalhaes S, Leandro K, et al
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer's
Disease.
J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231239.
- CABRERA-LEON Y, Baez PG, Fernandez-Lopez P, Suarez-Araujo CP, et al
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of
Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.
J Alzheimers Dis. 2024 Mar 10. doi: 10.3233/JAD-231271.
- ZHONG P, Cao Q, Yan Z
Distinct and Convergent Alterations of Entorhinal Cortical Circuits in Two Mouse
Models for Alzheimer's Disease and Related Disorders.
J Alzheimers Dis. 2024 Mar 14. doi: 10.3233/JAD-231413.
J Neurol Neurosurg Psychiatry
- ANDERSON EL, Davies NM, Korologou-Linden R, Kivimaki M, et al
Dementia prevention: the Mendelian randomisation perspective.
J Neurol Neurosurg Psychiatry. 2024;95:384-390.
Nature
- LANDHUIS E
Researchers call for a major rethink of how Alzheimer's treatments are evaluated.
Nature. 2024;627:S18-S20.
- HANEY MS, Palovics R, Munson CN, Long C, et al
APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia.
Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07185.
Nervenarzt
- BELTRANI S, Funk J, Lieb J, Ehrensperger MM, et al
[An arachnoid cyst mimicking a symptomatic Alzheimer's disease].
Nervenarzt. 2024 Mar 14. doi: 10.1007/s00115-024-01638.
Neurobiol Aging
- ALMEIDA FC, Jesus T, Coelho A, Quintas-Neves M, et al
Psychosis in Alzheimer's disease is associated with specific changes in brain MRI
volume, cognition and neuropathology.
Neurobiol Aging. 2024;138:10-18.
Neurologia (Engl Ed)
- ZHANG WT, Zhang GX, Gao SS
The potential diagnostic accuracy of circulating microRNAs for Alzheimer's
disease: A meta-analysis.
Neurologia (Engl Ed). 2024;39:147-159.
Neurology
- WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al
Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid
and Tau Burden 15 Years Later in Dementia-Free Adults.
Neurology. 2024;102:e209198.
- OVEISGHARAN S, Grodstein F, Evia AM Jr, James BD, et al
Association of Age-Related Neuropathologic Findings at Autopsy With a
Claims-Based Epilepsy Diagnosis in Older Adults.
Neurology. 2024;102:e209172.
- LI G, Iliff J, Shofer J, Mayer CL, et al
CSF beta-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain
Injury.
Neurology. 2024;102:e209197.
- ALOSCO ML, Tartaglia MC
Repetitive Blast Injury and CSF Alzheimer Disease Biomarkers: Navigating a
Complex Narrative.
Neurology. 2024;102:e209294.
- NGUYEN HV, Mital S, Knopman DS, Alexander GC, et al
Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer
Disease.
Neurology. 2024;102:e209218.
- NADEAU SE
Lecanemab Questions.
Neurology. 2024;102:e209320.
- NELSON SE, Lopez OL
Lecanemab for Alzheimer Disease: Is It Worth It?
Neurology. 2024;102:e209265.
- LU Y, Pike JR, Hoogeveen R, Walker K, et al
Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma
Biomarkers of Alzheimer Disease and Vascular Pathology.
Neurology. 2024;102:e209203.
- ASKEN BM, Tanner JA, Vandevrede L, Apple A, et al
Linking Type and Extent of Head Trauma to Cavum Septum Pellucidum in Older Adults
With and Without Alzheimer Disease and Related Dementias.
Neurology. 2024;102:e209183.
PLoS One
- SHAHID SS, Dzemidzic M, Butch ER, Jarvis EE, et al
Estimating the synaptic density deficit in Alzheimer's disease using
multi-contrast CEST imaging.
PLoS One. 2024;19:e0299961.
Science
- PILLER C
'Damning' FDA inspection report undermines Alzheimer's drug.
Science. 2024;383:1165-1166.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016